Primary Risk Prevention

Identify and treat key risk factors such as inflammation, metabolic disturbances, hormone imbalance, and toxin accumulation.

Early intervention in high-risk groups such as:

• Those with a history of cancer in first-degree relatives
• Women with premature menarche or late menopause (associated with breast and ovarian cancers)
• Those with genetic susceptibility (e.g., BRCA mutation carriers)
• Those with obesity, diabetes, or autoimmune disorders
• Those with long-term carcinogen exposure, like smoking, alcohol, and radiation, etc.

Secondary Prevention

• Managing early-stage and pre-malignant lesions conservatively
• Managing comorbidities contributing to cancer progression.

Adjuvant Care

• Reducing cancer treatment-related side effects such as fatigue, neuropathy, pain, and mucositis.
• Increasing tolerance to radiation and chemotherapy.
• Enhancing immune function to minimise the risk of infection

Tertiary Prevention

• Managing residual side effects like fatigue and sleep disturbance
• Managing weight-related comorbidities, poor sugar control, cardiovascular health, and enhancing the general quality of life.
• Managing functional challenges associated with different types of cancer, such as pulmonary rehabilitation and musculoskeletal impairments.

Survivorship: For patients in remission or who are fully cured

• ICC emphasises functional recovery, prevention of relapse by addressing risk factors, and long-term well-being through dietary, lifestyle, and psychological support.
• Managing late-stage treatment effects like lymphedema, bone loss, and hormonal imbalances.

Palliative Care:

• Pain and symptomatic relief
• Psychosocial support for patients and families

End-of-Life Care

• Ayurveda treatment for cancer stage 4 ensures maximum quality of life in the final stages.
• Prioritising symptom management and emotional well-being for both patients and caregivers.

Major Cancers Covered

• Breast Cancer
• Colorectal Cancer
• Head and Neck Cancer
• Prostate Cancer
• Esophageal and Stomach Cancer
• Hepatocellular Carcinoma
• Pancreatic Cancer
• Gallbladder Cancer
• Urinary Bladder Cancer
• Haematological Malignancies
• Brain Tumours
• Lung Carcinoma
• Ovarian and Endometrial Cancer

Cancer and its therapies disrupt the body’s metabolic balance, leading to overnutrition or undernutrition, which impacts patient outcomes. Poor dietary intake, inflammation, metabolic imbalances, and hormonal changes contribute to weight fluctuations, loss of muscle mass, immune dysfunction, and disease progression.
In Ayurveda, Agni Dushti (impaired digestion) produces Ama (toxins) that get accumulated in the body, creating a toxic environment conducive to cancer cell growth and spread. Further, it also compromises the immunity of cancer-afflicted patients.
AyurVAID’s Precision Treatment Protocol
Addresses undernutrition and overnutrition
Our personalised dietetics, Amapachana protocols, and gut-centric therapies support metabolic flexibility and enhance treatment responsiveness. Better gut health can positively impact the immune system and reduce systemic inflammation and tumour growth.